BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29581754)

  • 21. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs.
    Lei F; Lei T; Huang Y; Yang M; Liao M; Huang W
    Curr Mol Pharmacol; 2020; 13(3):192-205. PubMed ID: 31880267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxic nasopharyngeal carcinoma-derived exosomal miR-455 increases vascular permeability by targeting ZO-1 to promote metastasis.
    Xie L; Zhang K; You B; Yin H; Zhang P; Shan Y; Gu Z; Zhang Q
    Mol Carcinog; 2023 Jun; 62(6):803-819. PubMed ID: 36929868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.
    Liao C; Liu H; Luo X
    Am J Cancer Res; 2021; 11(6):2508-2520. PubMed ID: 34249413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 26. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.
    Lee PJ; Sui YH; Liu TT; Tsang NM; Huang CH; Lin TY; Chang KP; Liu SC
    J Exp Clin Cancer Res; 2022 Aug; 41(1):254. PubMed ID: 35986369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.
    Xiao D; Barry S; Kmetz D; Egger M; Pan J; Rai SN; Qu J; McMasters KM; Hao H
    Cancer Lett; 2016 Jul; 376(2):318-27. PubMed ID: 27063098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
    Jia Z; Jia J; Yao L; Li Z
    Front Immunol; 2022; 13():900155. PubMed ID: 35663957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells.
    Mrizak D; Martin N; Barjon C; Jimenez-Pailhes AS; Mustapha R; Niki T; Guigay J; Pancré V; de Launoit Y; Busson P; Moralès O; Delhem N
    J Natl Cancer Inst; 2015 Jan; 107(1):363. PubMed ID: 25505237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the role of exosome-derived long non-coding RNAs in hepatocellular carcinoma].
    Zhou C; Wang CJ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):77-81. PubMed ID: 30685932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in exosomal miRNA profile upon epithelial-mesenchymal transition in human lung cancer cell lines.
    Tang YT; Huang YY; Li JH; Qin SH; Xu Y; An TX; Liu CC; Wang Q; Zheng L
    BMC Genomics; 2018 Nov; 19(1):802. PubMed ID: 30400814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle.
    Zhou R; Wang L; Zhao G; Chen D; Song X; Momtazi-Borojeni AA; Yuan H
    IUBMB Life; 2020 Dec; 72(12):2546-2562. PubMed ID: 33053610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.
    Aga M; Bentz GL; Raffa S; Torrisi MR; Kondo S; Wakisaka N; Yoshizaki T; Pagano JS; Shackelford J
    Oncogene; 2014 Sep; 33(37):4613-22. PubMed ID: 24662828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unfolding the Complexity of Exosome-Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma.
    Chak PT; Kam NW; Choi TH; Dai W; Kwong DL
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis.
    Li DK; Chen XR; Wang LN; Wang JH; Li JK; Zhou ZY; Li X; Cai LB; Zhong SS; Zhang JJ; Zeng YM; Zhang QB; Fu XY; Lyu XM; Li MY; Huang ZX; Yao KT
    Cancer Gene Ther; 2022 Oct; 29(10):1439-1451. PubMed ID: 35388172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.